Researcher
Wim Robberecht
- Disciplines:Neurosciences, Biological and physiological psychology, Cognitive science and intelligent systems, Developmental psychology and ageing
Affiliations
- Laboratory for Neurobiology (VIB-KU Leuven) (Lab)
Member
From1 Jan 2012 → Today - Research Group Experimental Neurology (Division)
Member
From1 Oct 1999 → 31 Dec 2011
Projects
1 - 10 of 29
- Identification, characterization and validation of modifiers of repeat RNA toxicity in C9orf72 amyotrophic lateral sclerosis (ALS)From1 Oct 2018 → 28 Feb 2023Funding: FWO fellowships
- Clin-IC: Medtech solutions for patientsFrom1 May 2018 → TodayFunding: IOF - mandates, IOF - Industrial Research Fund
- Investigating modifiers of C9orf72 induced pathology in Amyotrophic Lateral Sclerosis (ALS) using zebrafish.From1 Jan 2017 → 31 Dec 2019Funding: Foundations, funds and other with scientific goal
- Investigating modifiers of C9orf72 induced pathology in Amyotrophic Lateral Sclerosis (ALS) using zebrafish.From1 Oct 2014 → 30 Sep 2018Funding: FWO fellowships
- The role of EphA4 in neural repair following ischemic strokeFrom1 Apr 2014 → 16 Mar 2020Funding: BOF - Doctoral projects, FWO fellowships
- JP ND-ALS-CarE : A programme for ALS Care in Europe.From1 Feb 2014 → 31 Jan 2019Funding: FWO research project (including WEAVE projects)
- Identifying COL4A1 and COL4A2 mutations in sporadic cerebral white matter diseaseFrom1 Jan 2014 → 31 Dec 2014Funding: FWO research grant KAN
- The ephrin axon repellent system in amyotrophic lateral sclerosis (ALS).From1 Jan 2014 → 31 Dec 2016Funding: Foundations, funds and other with scientific goal
- The ephrin axonal repellent system in Amyotrophic Lateral Sclerosis.From1 Jan 2014 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
- The mechanism of mutant C9orf72 in the pathogenesis of Amyotrophic Lateral Sclerosis/Frontotemporal Lobe Degeneration.From1 Jan 2014 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
Publications
31 - 40 of 198
- Molecular Dissection of FUS Points at Synergistic Effect of Low-Complexity Domains in Toxicity(2018)
Authors: Elke Bogaert, Steven Boeynaems, Jolien Steyaert, Joost Schymkowitz, Frederic Rousseau, Patrick Callaerts, Wim Robberecht, Philip Van Damme, Ludo Van Den Bosch
Pages: 529 - + - CHCHD10 variants in amyotrophic lateral sclerosis: Where is the evidence?(2018)
Authors: Matthieu Moisse, Philip Van Damme, Wim Robberecht
Pages: 110 - 116 - In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration(2018)
Authors: Robert Ciarán Prior, Wim Robberecht, Ludo Van Den Bosch
- Efficacy and safety of intravenous Immunoglobulin (IVIG) IgPro10 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): combined analysis of the PRIMA and PATH studies(2018)
Authors: Wim Robberecht
Pages: 468 - 469 - EFFICACY AND SAFETY OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) IGPRO10 IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP)(2018)
Authors: Arman Sabet, Orell Mielke, Ivo N van Schaik, Jean-Marc Leger, Vera Bril, Nan van Gloven, Hans Peter Hartung, Richard A Lewis, Gen Sobue, John-Philip Lawo, et al.
Pages: E19 - E19 - Elongator subunit 3 (ELP3) modifies ALS through tRNA modification(2018)
Authors: Bart Swinnen, Caroline Eykens, Annelies Nonneman, Rik Nuyts, Robin Lemmens, Deirdre Cabooter, Ludo Van Den Bosch, Philip Van Damme, Wim Robberecht
Pages: 1276 - 1289 - A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism(2018)
Authors: Bart Swinnen, Steven Boeynaems, Elke Bogaert, Rik Nuyts, Robin Lemmens, Philip Van Damme, Ludo Van Den Bosch, Wim Robberecht
Pages: 427 - 443 - Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growth(2018)
Authors: Lawrence Van Helleputte, Caroline Eykens, Elisabeth Rossaert, Pieter Vanden Berghe, Conny Gysemans, Chantal Mathieu, Wim Robberecht, Philip Van Damme, Ludo Van Den Bosch
Pages: 59 - 69 - Genome-wide Analyses Identify KIF5A as a Novel ALS Gene(2018)
Authors: Ludo Van Den Bosch, Matthieu Moisse, Philip Van Damme, Wim Robberecht
Pages: 1268 - 1283 - Reconsidering the causality of TIA1 mutations in ALS(2018)
Authors: Rick A Van Der Spek, Wouter Van Rheenen, Sara L Pulit, Kevin P Kenna, Nicola Ticozzi, Maarten Kooyman, Russell L McLaughlin, Matthieu Moisse, Kristel R Van Eijk, Joke JFA Van Vugt, et al.
Pages: 1 - 3
Patents
1 - 6 of 6
- Single domain antibodies against sod1 and their use in medicine (Inventor)
- Hdac inhibitors to treat charcot-marie-tooth disease (Inventor)
- SINGLE DOMAIN ANTIBODIES AGAINST SOD1 AND THEIR USE IN MEDICINE (Inventor)
- HDAC inhibitors to treat charcot-marie-tooth disease (Inventor)
- SINGLE DOMAIN ANTIBODIES AGAINST SOD1 AND THEIR USE IN MEDICINE (Inventor)
- USE OF EPHRIN TYPE-A RECEPTOR 4 SIGNALING INHIBITOR FOR TREATMENT OF MOTOR NEURON DISEASE CHOSEN FROM AMYOTROPHIC LATERAL SCLEROSIS AND SPINAL MUSCULAR ATROPHY (Inventor)